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Autism

spectrum disorders

Autism is a complex neurobiological, developmental disorder that is typically diagnosed in childhood with symptoms that often last throughout a person’s lifetime. Autism
is part of a group of disorders known as autism spectrum
disorders (ASD), characterized by varying degrees of
symptom severity and impact, ranging from mild to quite
severe. The hallmark characteristics of autism include an
impaired ability to communicate and relate to others socially. Autism is also associated with a restricted range of
activities and repetitive behaviors, such as obsessively arranging objects or following very specific routines.
ASD can usually be reliably diagnosed behaviorally by 24
months of age although new and promising research aims to
establish screening and diagnostic measures for children as
young as 12-18 months1. While there is no known cure, research indicates that early intervention in an appropriate educational setting for at least two years during the preschool
years can result in significant improvements in language,
cognitive ability, and social skills for many young children
with autism spectrum disorders2,3.

ASD

epidemiology

The prevalence of ASD is not documented in many countries around the world, with most information coming
from regions such as in Europe and the United States,
where standardized diagnostic approaches are available.
Despite some preliminary efforts4 there is not a reliable
population-based prevalence estimate published in Brazil, nor in any other Latin America country5. In the last
two decades of epidemiological research, best-estimates
of ASD prevalence ranged anywhere from 4/10,000 to
6/1,0006. The most recent estimates of ASD prevalence in
the U.S.7,8 and other Western nations9 indicate that almost
1% of children are affected. Based on these international
estimates, it is conceivable that as many as 1.5 million Brazilians are currently living with ASD.
While the apparent increase in ASD prevalence may be
due in part to shifting diagnostic practices and increased
awareness, these factors alone may not explain the entire
2

increase. Other risk factors that may be contributing to
the increase in prevalence remain unknown and warrant
further investigation10,11. What is known is that autism affects far more individuals than previously imagined and
the cost of autism is staggering. The economic cost of this
disorder in the U.S. is close to $35 billion annually12. These
numbers may be even higher in cases with co-morbid disorders and autism.
The neurodevelopmental deficits underlying ASD are
believed to transcend racial, ethnic, sociocultural, and
geographic boundaries, thus there is increasing momentum to examine autism internationally. Such investigation
will begin to address the more perplexing epidemiologic
questions surrounding autism including how prevalence
varies between settings and what factors, either genetic or
environmental, may influence the prevalence and phenotypic expression of ASD. However major barriers stand
in the way of conducting research and providing services
to those affected by autism around the world. Levels of
awareness, research capacity, service availability, and local
beliefs about behavioral differences differ markedly across
countries. In addition, the burden autism presents on society is unknown due to the absence of reliable epidemiologic data on prevalence.
Well designed, robust epidemiological research is required to help professionals and governments identify autism as a public health priority, and to provide a platform
for autism policy reform. This is the case for Brazil. The
guidelines of the Brazilian Public Health System (SUS)
suggest that actions of public policy must be based on
scientific evidence13. From a public health perspective, research on ASD conducted in a particular country is very
important to estimate the magnitude of ASD, its etiology,
and how to plan strategies of intervention. The ultimate
goal of autism research is to improve the care and the outcomes for individuals with ASD and their family.

International

leadership

International organizations have played an important
role in encouraging the recognition of autism and other
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mental health issues worldwide, and in guiding local
decision-makers on the development of necessary public health policies. An interesting example is the current
Grand Challenges in Global Mental Health (GCGMH),
involving NIMH, WHO, London School, among other
internationally recognized organizations. This consortium
of international researchers is seeking consensus on the
major barriers to improving research and provision of services in autism and mental health around the globe.
For autism-specific activities, it is important to highlight the efforts of Autism Speaks. Autism Speaks (AS) is
the world’s largest autism science and advocacy organization in the world, dedicated to changing the lives for all
who struggle with autism by enhancing and supporting
autism awareness, research and services worldwide. In
2008, AS launched the Global Autism Public Health initiative (GAPH), an ambitious international advocacy effort
designed to: (1) enhance public and professional awareness of autism; (2) increase clinical and scientific expertise/capacity and promote international research collaborations; and (3) enable service development and training
in early detection and intervention around the world. The
GAPH development process and content are informed by
the latest findings in treatment research and by systematic
knowledge translation. The aim is to accelerate the delivery of meaningful benefits to individuals and families by
working collaboratively with all the stakeholders, including health, education, and other government officials,
expert clinicians and scientists, as well as families in the
community. In 2010, GAPH was introduced to the Brazilian autism community at the First Brazilian Meeting for
Autism Research.
AS has worked collaboratively with partners in Central and South America, as well as the Middle East, Asia,
and Africa on GAPH-related activities, including technical development, training, and awareness efforts. On the
research side, more than 100 investigators from over 30
countries currently participate in the International Autism
Epidemiology Network (IAEN). A component of GAPH,
the network promotes collaborative research by providing
a forum for communication and idea exchange between
epidemiologists from around the globe. Among the investigators who participate to IAEN and other GAPH efforts
are those from Brazil.
AS initiatives have facilitated meetings between Brazilian and international investigators, promoting collaboration and idea sharing on how to address the autism
research priorities in Brazil and around the world. One
such example is the partnership between AS and the International League Against Epilepsy (ILAE). As comorbid disorders are common among individuals with ASD,
this has become an area of key concern and focus among
the international autism research community. Epilepsy,
for instance, has been estimated to affect 20%-40% of
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autism cases14. The AS-ILAE partnership aims to establish
a bridge of communication between professionals working
in ASD and those working in epilepsy to address common
clinical and research objectives, and Brazil is also represented in this initiative.

Autism

in

Brazil

A recent systematic review of the Brazilian scientific
literature on ASD shed light on the current state of autism
science in Brazil. On one hand, the review demonstrated a
significant increase in the Brazilian autism scientific production in the last two years. On the other hand, it showed
that most of these publications are not focused on matters that contribute significantly to improving public
health surrounding autism in Brazil. Most publications
refer to uncontrolled intervention studies with small convenience samples, while epidemiological studies (a prevalence study, as a first step) and validation of diagnostic
and neuropsychological instruments are almost nonexistent. These efforts, as mentioned previously, are essential
for guiding public policies around the magnitude of and
response to the autism crisis. Another intriguing finding
of this review was the extreme concentration of scientific
production in only two Brazilian regions. Investigators
from southeast (mainly São Paulo) and south (particularly
Rio Grande do Sul) were first authors of almost 90% of all
papers published between 2002-200915.
The paucity of research utilizing more robust methodologies and the concentration of scientific production in
a small number of regions throughout the country reflect
the lack of specific funding for autism research in Brazil.
An additional consequence of this situation is the lack
of specialized human resources and a subsequent lack of
services for affected individuals and their families. In this
sense, the creation of centers of excellence, research consortiums, and unified community/family associations, at
national and international levels, are vital to enhancing
autism research and services in Brazil.

Brazilian Meeting

for

Autism Research -

learning

from the scientific and autism communities

In an effort to better understand the state of autism in
Brazil, a first-of-its-kind event took place in April 2010:
the 1st Brazilian Meeting for Autism Research (www.ufrgs.
br/ebpa2010). The meeting was a unique opportunity to
disseminate results of Brazilian autism research to the
scientific and parent communities as well as to promote
networking and collaboration between international and
Brazilian experts in clinical and basic sciences.
Over three days, speakers presented the latest results
and new scientific knowledge about autism to an audience of over 400 participants. Brazilian Public Policy for
autism was presented and discussed by government representatives from the Brazilian Ministries of Health and
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Education. In addition, Autism Speaks participated in the
event and presented the Global Autism Public Health Initiative as an approach to enhancing research, services, and
awareness that Brazil could contribute to. While most attendees were autism investigators and professionals from
the Health and Educational fields, there was also a strong
presence from the autism advocacy community representing numerous Brazilian autism organizations as well as
parents from across the country. These stakeholders had
a special one day meeting to debate their needs and main
barriers to achieve them, attended by over 100 parents.
During the meeting, data was collected from speakers
and stakeholders to identify current challenges and barriers to autism research and services. This was an effort
to define the consensus priorities around improving research, awareness and services for autism in Brazil. It is
envisioned that the following valuable information can be
used by research and service professionals, policymakers,
and/or community advocates to take more suitable decisions for autism in Brazil.
The main challenges and barriers identified included:
• Lack of specific funding support for autism research
• Lack of well-trained investigators and clinicians in
several disciplines
• Lack of multicenter national and international projects
• Lack of robust scientific studies, relying on large
sample sizes
• Scientific evidence originates mostly from only two
Brazilian States
• Lack of awareness campaigns to enhance understanding among the general public and professionals
in the health and education systems
The priority areas identified in response to these challenges were as follows:
1. Research
• Build capacity for research in diverse disciplines (e.g.
epidemiology, psychology, genetics, etc.) through research training programs around the country
• Promote clinical training, including training in diagnostic instruments, early detection and evidence
based interventions
• Determine the prevalence of autism in Brazil to be
used for public health policy planning
• Investigate the impact and success of national education inclusion program in regular schools settings
• Implement strategies to achieve financial support
from main Brazilian funding agencies (FAPESP,
CAPES and CNPQ)
• Encourage collaboration between Brazilian investigators, and between Brazilian investigators and international experts.
2. Awareness
• Raise public understanding and improve public per4

ception of autism by making information more accessible to the public
• Address detection of children through the public
systems, principally in primary care and school settings;
• Address the needs for information on adolescent/
adult care and services
• Disseminate the latest key scientific findings to the
Brazilian community
3. Services
• Enhance understanding of current approaches and
best practices in service provision among Brazilian
providers
• Build capacity for services in Brazil among professionals and in community-based settings
• Establish training program for screening early detection and intervention strategies, such as instruction
to pediatricians and primary care clinicians.

Conclusions
As demonstrated by the success of the Brazilian Meeting for
Autism Research as well as previous and ongoing research
activities, there is much potential for Brazil to enhance its
presence in the world of ASD research. In addition, Brazil
can continue to be a leader in Latin America, producing
high-quality and impactful ASD research. There is much
research that remains to be completed in ASD research,
and Brazil is in the unique position to address unanswered
questions in autism epidemiology and etiology. For example, the Brazilian population is highly diverse: 43%
of the population is composed of persons of mixed race.
Within this context, we would be able to explore associations between race and specific manifestations of the ASD.
No studies are currently known which examine ASD in a
mixed race population.
Our first recommendation is that future Brazilian autism research should be focused on understanding and
improving issues related to public health. This includes
developing guidelines to inform the SUS. In addition, the
first population-based Brazilian prevalence study of ASD
is crucial to inform public health policy. We expect that
results from these activities will provide a solid foundation
on which Brazilians can work together to address the challenges and barriers previously identified by experts and
stakeholders in the Brazilian autism community.
Another key element to be addressed in the next few
years is to increase clinical and scientific expertise, encompassing the various disciplines involved in the field of
autism research and services. The creation of centers of
excellence with the aim of training professionals in the
areas of health and education is a demonstrated approach
to enhancing professional capacity. Additionally, the establishment of national networks and unified associations
would help accelerate the pace of scientific production by
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galvanizing the Brazilian autism expert community. Together, these activities can improve the understanding of
autism in Brazil, Latin America, and around the world by
contributing meaningful scientific knowledge to the field.
At the same time, the Brazilian autism community will
benefit from the added expertise and capacity to provide
much needed autism diagnostic and intervention services
to those affected individuals and their families.
ASD cannot be considered a rare disorder anymore
and over a million Brazilians are likely to be affected. The
health and educational public systems must be prepared to
assist this population in dire need of support. The above
recommendations will start to address these challenges
as well as begin to develop a sustainable system of service
and research specialists in Brazil. Recent activities among
Brazilian autism professionals including the 1st Brazilian
Meeting for Autism Research should be seen as positive
and forward movement in the effort to address autism in
Brazil, however it is only scratching the surface of the efforts still needing. It is important for the Brazilian community to build on these efforts by supporting and investing
in future autism research.
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